Release date: 2007-07-17 A comprehensive review on the treatment of obstructive sleep apnea-hypopnea syndrome (OSAHS) in children has highlighted the importance of surgical intervention as the primary therapeutic approach. Adenoidectomy, often combined with tonsillectomy, is widely considered the standard treatment for this condition. However, outcomes can be unsatisfactory due to various factors such as obesity, nasal disorders, and improper patient selection. OSAHS is a common disorder among children, characterized by loud snoring, breathing pauses during sleep, and frequent episodes of low oxygen levels. These disturbances can lead to daytime sleepiness, cardiovascular issues, and even long-term organ damage, significantly impacting a child’s quality of life and development. A study published in the February issue of the Chinese Journal of Otorhinolaryngology Head and Neck Surgery examined the effectiveness of surgical treatment in a group of pediatric patients. The research followed 243 children who underwent adenoidectomy and/or tonsillectomy between June 2004 and June 2006 at Beijing Children's Hospital, Capital Medical University. The patients ranged in age from 1 year and 5 months to 14 years. All were monitored before and after surgery using multi-channel sleep studies, and their progress was evaluated based on symptom improvement, apnea-hypopnea index (AHI), and oxygen saturation levels. The results showed that 90.9% of the children experienced complete recovery. However, 22 patients had an AHI greater than 5.0 events per hour, and 5 cases still reported symptoms before improvement. Additionally, 17 patients showed little or no clinical improvement. Further analysis revealed that some of these cases had underlying conditions such as nasal disease, pectus excavatum, cerebral palsy, or enlarged turbinates. For these patients, additional treatments such as medication, reoperation, or ventilator support were necessary to achieve better outcomes. This study emphasizes that while surgical removal of the adenoids and tonsils remains the most effective treatment for OSAHS in children, it is crucial to carefully assess each patient’s individual case. Addressing comorbidities and ensuring proper indications for surgery can greatly enhance treatment success. As medical knowledge continues to evolve, so too should the approaches to managing this complex condition. ——Midi Medical Network Animal Medicine Premix,Tilmicosin Premix,Tylvalosin Tartrate Premix,Animal Products Medicine Sichuan Aibang Weiye Biological Engineering Co., Ltd. , https://www.aibangpharm.com